ArticleBMC cancer2021

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin.

Wendy Muñoz-Montaño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.